Table 1 Distribution of MDR bacterial uropathogens
From: High prevalence of multidrug resistance in bacterial uropathogens from Kathmandu, Nepal
Organism | In hospitalized-patient | In out-patient | Total | |||
|---|---|---|---|---|---|---|
| Â | No of isolates (%) | No of MDR isolates (%) | No of isolates (%) | No of MDR isolates (%) | No of isolates (% of total) | No of MDR isolates (%) |
Acinetobacter spp. | 1 | 1 (100) | 1 | 0(0) | 2 (0.9) | 1 (50) |
Citrobacter spp. | 5 | 5 (100) | 6 | 3 (50) | 11 (5) | 8 (72.7) |
Enterobacter spp. | 0 | 0 (0) | 4 | 1 (25) | 4 (1.8) | 1 (25) |
Escherichia coli | 11 | 8 (72.7) | 167 | 60 (35.9) | 178 (81.3) | 68 (38.2) |
Klebsiella oxytoca | 0 | 0 (0) | 2 | 1 (50) | 2 (0.9) | 1 (50) |
K. pneumoniae | 0 | 0 (0) | 4 | 1 (25) | 4 (1.8) | 1 (25) |
Morganella morganii | 0 | 0 (0) | 2 | 0 (0) | 2 (0.9) | 0 (0) |
Proteus mirabilis | 0 | 0 (0) | 3 | 0 (0) | 3 (1.4) | 0 (0) |
Pseudomonas aeruginosa | 0 | 0 (0) | 2 | 2 (100) | 2 (0.9) | 2 (100) |
Salmonella typhi | 1 | 1(100) | 0 | 0(0) | 1 (0.5) | 1 (100) |
Staphylococcus aureus | 0 | 0(0) | 1 | 1 (100) | 1 (0.5) | 1 (100) |
CoNS* | 1 | 1 (100) | 5 | 2 (40) | 6 (2.7) | 3 (50) |
Enterococcus faecalis | 1 | 1(100) | 2 | 2 (100) | 3 (1.4) | 3 (100) |
Total | 20 | 17 (85) | 199 | 73 (36.7) | 219 (100) | 90 (41.1) |